Prognostic Value of a Nine‐Gene Signature in Glioma Patients Based on mRNA Expression Profiling

Gliomas are the most common primary brain tumors in adults and a significant cause of cancer‐related mortality. A 9‐gene signature was identified as a novel prognostic model reflecting survival situation obviously in gliomas.

[1]  Rika Nakayama,et al.  Tead proteins activate the Foxa2 enhancer in the node in cooperation with a second factor , 2005, Development.

[2]  N. Hay,et al.  Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein, Max, for positive regulation of cardiac alpha-myosin heavy-chain gene expression , 1997, Molecular and cellular biology.

[3]  M. Monden,et al.  Cancer cells survive with survivin , 2008, Cancer science.

[4]  K. Guan,et al.  Regulation of Integrin β1 Recycling to Lipid Rafts by Rab1a to Promote Cell Migration* , 2010, The Journal of Biological Chemistry.

[5]  Markus Weininger,et al.  Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin , 2006, Cancer Immunology, Immunotherapy.

[6]  R. Kanwar,et al.  Targeting survivin in cancer: patent review , 2010, Expert opinion on therapeutic patents.

[7]  J. Becker,et al.  The Universal Character of the Tumor-Associated Antigen Survivin , 2007, Clinical Cancer Research.

[8]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[9]  J. Luketich,et al.  Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. , 1999, The Annals of thoracic surgery.

[10]  T. Jiang,et al.  Whole‐genome microRNA expression profiling identifies a 5‐microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme , 2013, Cancer.

[11]  John Quackenbush.  Microarray analysis and tumor classification. , 2006, The New England journal of medicine.

[12]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[13]  Lei Han,et al.  Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group. , 2012, Neuro-oncology.

[14]  P. Gimenez-Bonafe,et al.  Overcoming drug resistance by enhancing apoptosis of tumor cells. , 2009, Current cancer drug targets.

[15]  Paul S Mischel,et al.  Targeted Molecular Therapy of GBM , 2003, Brain pathology.

[16]  J. Ji,et al.  Transcription Enhancer Factor 1 Binds Multiple Muscle MEF2 and A/T-Rich Elements during Fast-to-Slow Skeletal Muscle Fiber Type Transitions , 2003, Molecular and Cellular Biology.

[17]  Yuri Kotliarov,et al.  Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. , 2009, Cancer research.

[18]  T. Jiang,et al.  Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma. , 2013, Cancer letters.

[19]  M. Malumbres,et al.  Mitotic Stress and Chromosomal Instability in Cancer: The Case for TPX2. , 2012, Genes & cancer.

[20]  R. Wilson,et al.  Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.

[21]  Ash A. Alizadeh,et al.  Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. , 2004, The New England journal of medicine.

[22]  M. Duffy,et al.  Survivin: a new target for anti-cancer therapy. , 2009, Cancer treatment reviews.

[23]  C. Ji,et al.  Molecular Cloning and Characterization of a Novel Human Putative Transmembrane Protein Homologous to Mouse Sideroflexin Associated with Sideroblastic Anemia , 2003, DNA sequence : the journal of DNA sequencing and mapping.

[24]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[25]  G. Tsujimoto,et al.  cDNA microarray analysis of esophageal cancer: discoveries and prospects , 2009, General thoracic and cardiovascular surgery.

[26]  R. Schwartz,et al.  Physical Interaction between the MADS Box of Serum Response Factor and the TEA/ATTS DNA-binding Domain of Transcription Enhancer Factor-1* , 2001, The Journal of Biological Chemistry.

[27]  J. Luketich,et al.  Endoscopic ultrasound compared with laparoscopy for staging esophageal cancer. , 2007, The Annals of thoracic surgery.

[28]  Tao Jiang,et al.  Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. , 2013, Cancer letters.

[29]  E Günter,et al.  Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial , 2004, Gut.

[30]  Huang-Hui Chen,et al.  Investigations of survivin: the past, present and future. , 2011, Frontiers in bioscience.

[31]  J. Epstein,et al.  Identification of minimal enhancer elements sufficient for Pax3 expression in neural crest and implication of Tead2 as a regulator of Pax3 , 2004, Development.

[32]  Yingying Wang,et al.  Increased α-Tubulin1b Expression Indicates Poor Prognosis and Resistance to Chemotherapy in Hepatocellular Carcinoma , 2013, Digestive Diseases and Sciences.

[33]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[34]  C. Brancolini,et al.  Ubiquitin-dependent degradation of HDAC4, a new regulator of random cell motility , 2011, Molecular biology of the cell.

[35]  Shin Jung,et al.  Role of metallothionein 1E in the migration and invasion of human glioma cell lines. , 2012, International journal of oncology.

[36]  V. Rao,et al.  Plant-based diets and control of lipids and coronary heart disease risk , 2008, Current atherosclerosis reports.

[37]  J. Pober,et al.  Control of apoptosis during angiogenesis by survivin expression in endothelial cells. , 2000, The American journal of pathology.